Early Palliative Care for Patients With Severe and Very Severe COPD: a Randomised Study
Can Early Introduction of Specialized Palliative Care Limit Intensive Care, Emergency and Hospital Admissions in Patients With Severe and Very Severe COPD? A Randomized Study
2 other identifiers
interventional
51
1 country
1
Brief Summary
Chronic obstructive pulmonary disease (COPD) is a common and, despite existing treatment options, progressive lung disease. Patients with COPD often have only limited access to palliative care. The goal of this research project is to improve the quality of life of patients with COPD. Background In many cases, the symptoms of advanced COPD (including shortness of breath, pain and depression) are insufficiently alleviated. In addition, often in connection with an infection, patients frequently suffer from respiratory decompensation; this may lead to invasive interventions as well as the admission to the emergency room or an intensive care unit. It may ultimately lead to the death of the patient. Aim This study aims to show that early palliative care can reduce the number of necessary invasive interventions and improve the quality of life of patients with COPD. For this purpose, a group of patients receiving early, standardized palliative care will be compared to a group of patients receiving customary treatment only, without systematic intervention by palliative care experts. Significance The results of this study should make it possible to efficiently use the medical resources which are required for the appropriate care of patients with COPD. The goal is the best possible quality of life and better coordination of the measures taken, especially with regard to the area of acute care and the wishes of the patient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2013
CompletedFirst Submitted
Initial submission to the registry
August 8, 2014
CompletedFirst Posted
Study publicly available on registry
August 22, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2017
CompletedNovember 8, 2021
October 1, 2021
3.8 years
August 8, 2014
October 31, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
length of stay hospital, intensive care unit and emergency admissions
number of days
1 year
Secondary Outcomes (2)
depression and anxiety
1 year
Health related quality of life assessed by a generic questionnaire
1 year
Study Arms (2)
control
PLACEBO COMPARATORstandard management
early palliative care
ACTIVE COMPARATORearly palliative care
Interventions
the patients will benefit from an early palliative care consultation
Eligibility Criteria
You may qualify if:
- COPD defined according to GOLD criteria (FEV1/FVC \< 70%) stage III or IV (FEV1 \< 50% predicted)
- and/or long term treatment with either domiciliary oxygen or home mechanical ventilation
- and or one or more hospital admissions in the previous year for an acute exacerbation
You may not qualify if:
- Moderate or severe cognitive impairment (MMSE\<20)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Genevalead
- Swiss National Science Foundationcollaborator
Study Sites (1)
University Hospital Geneva
Geneva, Switzerland
Related Publications (1)
Weber C, Stirnemann J, Herrmann FR, Pautex S, Janssens JP. Can early introduction of specialized palliative care limit intensive care, emergency and hospital admissions in patients with severe and very severe COPD? a randomized study. BMC Palliat Care. 2014 Oct 21;13:47. doi: 10.1186/1472-684X-13-47.
PMID: 25927907DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Paul Janssens, MD
University Hospital, Geneva
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 8, 2014
First Posted
August 22, 2014
Study Start
September 1, 2013
Primary Completion
July 1, 2017
Study Completion
July 1, 2017
Last Updated
November 8, 2021
Record last verified: 2021-10